Showing results (471-480 of 550) with videos related to
Sort By:
Pageof 55
The New England Journal of Medicine|May 22, 2019
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome, Marc Moss, David T Huang, et al.Intensive Care Medicine|October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabRichard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.Journal of Intensive Care|April 2, 2016
Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failureAlexandre Mebazaa, Pierre François Laterre, James A Russell, et al.Critical Care (London, England)|July 21, 2026
Twenty-five years of septic shock hemodynamic resuscitation trials: a conceptual perspectiveGlenn Hernandez, Oliver Hunsicker, Daniel de Backer, et al.Intensive Care Medicine|February 22, 2021
How the COVID-19 pandemic will change the future of critical careYaseen M Arabi, Elie Azoulay, Hasan M Al-Dorzi, et al.Intensive Care Medicine|August 21, 2013
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe, David T Huang, Derek C Angus, et al.JAMA|May 20, 2019
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisChristopher W Seymour, Jason N Kennedy, Shu Wang, et al.JAMA|April 27, 2016
Effect of a Quality Improvement Intervention With Daily Round Checklists, Goal Setting, and Clinician Prompting on Mortality of Critically Ill Patients: A Randomized Clinical Trial, Alexandre B Cavalcanti, Fernando Augusto Bozza, et al.JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.BMJ Open|April 3, 2023
Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injuryPeter Pickkers, Derek C Angus, Jacques Arend, et al.Pageof 55